These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13328762)

  • 1. [Bacteriologic research on the effect of viomycin on Mycobacterium tuberculosis].
    BARTMANN K; BLISSE A; ZANDER I
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 115(3):211-22. PubMed ID: 13328762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viomycin, a new tuberculostatic antibiotic].
    LEVADITI C; VAISMAN A; HENRY-EVENO J; CHAIGNEAU-ERHARD H
    Rev Immunol Ther Antimicrob; 1951; 15(5-6):298-320. PubMed ID: 14942194
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of sensitivity threshold of Koch's bacillus to viomycin].
    GIUNIO N
    Tuberkuloza; 1955; 7(4):229-38. PubMed ID: 13312091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viomycin resistance].
    HERTEL HW; SCHOLTZE H
    Tuberkulosearzt; 1956 Jul; 10(7):405-10. PubMed ID: 13361009
    [No Abstract]   [Full Text] [Related]  

  • 5. The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis.
    SINGH B; MITCHISON DA
    J Gen Microbiol; 1955 Aug; 13(1):176-84. PubMed ID: 13252227
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 11. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basic studies on viomycin and tuberactinomycin (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Fujino T; Kaneko K
    Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 18. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental studies on the combined effect of kanamycin and viomycin.
    Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):62-9. PubMed ID: 4320009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of kanamycin and florimycin on intracellular located Mycobacterium tuberuclosis and some regularities of interaction of these antibiotics with body cells].
    Kivman GIa; Kosolapova AV; Petrova IV; Iakovlev VP
    Antibiotiki; 1969 Jun; 14(7):630-5. PubMed ID: 4309175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.